LeonaBio, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Four
LeonaBio, Inc. (LONA) had Lessee, Operating Lease, Liability, to be Paid, Year Four of $494.00 thousand as of 2021-12-31, per its 10-K filed 2022-03-28.
Discontinued › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour · last filed 2022-03-28
- 2021-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Four $494.00K.
- 2021-09-30: Lessee, Operating Lease, Liability, to be Paid, Year Four $494.00K.
- 2021-06-30: Lessee, Operating Lease, Liability, to be Paid, Year Four $494.00K.
- 2021-03-31: Lessee, Operating Lease, Liability, to be Paid, Year Four $443.00K.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year Four |
|---|---|
| 2021-12-31 | $494.00K 10-K · filed 2022-03-28 |
| 2021-09-30 | $494.00K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $494.00K 10-Q · filed 2021-08-16 |
| 2021-03-31 | $443.00K 10-Q · filed 2021-05-13 |
| 2020-12-31 | $277.00K 10-K · filed 2021-03-25 |
| 2020-09-30 | $277.00K 10-Q · filed 2020-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |